Dr. Patt is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2410 Round Rock Ave
Ste 150
Round Rock, TX 78681Phone(512) 427-9400
Fax(512) 687-0295- Is this information wrong?
Education & Training
University of Texas Health Science Center - HoustonFellowship, Medical Oncology, 2003 - 2006
Baylor College of MedicineResidency, Internal Medicine/Pediatrics, 1999 - 2003
Baylor College of MedicineClass of 1999
Certifications & Licensure
TX State Medical License 2003 - 2023- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) Start of enrollment: 2017 Jan 01Clinical Contact
- A Study of LY2835219 Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 01Panwalkar, A.,Tiersten, A.,WHITTENBERGER, B.,Stokoe, C.,Jones, C.,Patt, D.,Tamkus, D.,Khan, D.,Khan, F.,Holmes, F.,Wright, G.,Sledge, G.,Wang, G.,Koh, H.,Soliman, H.,Rugo, H.,Reynolds, J.,Vu, J.,Beck, J.,...
- A Study Of LY2835219 In Participants With Previously Treated Breast Cancer That Has Spread Start of enrollment: 2014 Jun 01Lindquist, D.,Patt, D.,Yardley, D.,Wright, G.,Wang, G.,Rugo, H.,Pippen, J.,Hart, L.,Modiano, M.,DICKLER, M.,Narang, M.,Gupta, M.,Ward, P.,Swain, S.,Tolaney, S.,Inst., S.C.,Lynch, S.,Bloom, S.,Anderson, T....
Publications & Presentations
PubMed
- Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer.Jeffrey Crawford, Neelima Denduluri, Debra A. Patt, Xiaolong Jiao, Phuong Khanh Morrow, Jacob Garcia, Richard Barron, Gary H. Lyman> ;Supportive Care in Cancer. 2020 Feb 1
- FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancerMafalda Oliveira, Cristina Saura, P Nuciforo, I. Calvo, Jay Andersen, José Luís Passos-Coelho, M. Gil Gil, Begoña Bermejo, Debra A. Patt, Eva Ciruelos, L de la Pena, N...> ;Annals of Oncology. 2019 Aug 1
- Using Big Data and Predictive Analytics to Determine Patient Risk in Oncology.Ravi B. Parikh, Andrew Gdowski, Debra A Patt, Andrew Hertler, Craig H. Mermel, Justin E. Bekelman> ;American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2019 May 17
- Join now to see all
Lectures
- Operationalizing a Risk Model in Clinical Practice: A Community Oncology PerspectiveASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Understanding Utilization Management-Policy Background: Forms of Utilization Management From a Clinician Perspective.2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Press Mentions
- New Study Warns of Negative Impact COVID-19 Is Having on Cancer Screenings, Diagnosis and TreatmentOctober 28th, 2020
- Here’s Why Breast Cancer Can Take A Long Time to DevelopOctober 23rd, 2020
Why Predictive Analytics Are Critical to Better Care DeliveryMay 5th, 2020- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Ascension Seton Medical Center AustinAustin, Texas- Cornerstone Hospital of CentralTXAustin, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
